 "Sputnik Covid-19 vaccine")
Dr Reddy’s Laboratories (DRL) has applied for emergency use authorisation with the Indian drug regulator for Sputnik V vaccine. Earlier, DRL had indicated that it aimed to launch the vaccine in March itself if it gets the regulator's nod.
It has lined up 250 million doses of the vaccine for Indian citizens (from manufacturing partners) over the next 12 months.
The human adenoviral vector (flu virus)-based vaccine candidate is developed by Gamaleya National Research Institute of Epidemiology and Microbiology in Russia and was registered in that country in August last year. DRL will present the safety profile of
It has lined up 250 million doses of the vaccine for Indian citizens (from manufacturing partners) over the next 12 months.
The human adenoviral vector (flu virus)-based vaccine candidate is developed by Gamaleya National Research Institute of Epidemiology and Microbiology in Russia and was registered in that country in August last year. DRL will present the safety profile of
